Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Correction for Shin et al., Histone Deacetylase Classes I and II Regulate Kaposi's Sarcoma-Associated Herpesvirus Reactivation.

Shin HJ, DeCotiis J, Giron M, Palmeri D, Lukac DM.

J Virol. 2016 May 27;90(12):5845. doi: 10.1128/JVI.00587-16. Print 2016 Jun 15. No abstract available.

2.

Histone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation.

Shin HJ, DeCotiis J, Giron M, Palmeri D, Lukac DM.

J Virol. 2014 Jan;88(2):1281-92. doi: 10.1128/JVI.02665-13. Epub 2013 Nov 13. Erratum in: J Virol. 2016 May 27;90(12):5845.

3.

The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency.

Guito J, Gavina A, Palmeri D, Lukac DM.

J Virol. 2014 Jan;88(1):547-58. doi: 10.1128/JVI.02877-13. Epub 2013 Oct 30.

4.

Kaposi's sarcoma-associated herpesvirus Rta tetramers make high-affinity interactions with repetitive DNA elements in the Mta promoter to stimulate DNA binding of RBP-Jk/CSL.

Palmeri D, Carroll KD, Gonzalez-Lopez O, Lukac DM.

J Virol. 2011 Nov;85(22):11901-15. doi: 10.1128/JVI.05479-11. Epub 2011 Aug 31.

5.

Antecubital allergic contact dermatitis from intravenous iron infusion: a possible etiological role of nickel.

Corazza M, Borghi A, Sarno O, Maranini C, Pagnoni A, Palmeri D, Virgili A.

Eur J Dermatol. 2011 Mar-Apr;21(2):284-6. doi: 10.1684/ejd.2011.1254. No abstract available.

PMID:
21324789
6.

Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.

Spadavecchia S, Gonzalez-Lopez O, Carroll KD, Palmeri D, Lukac DM.

J Virol. 2010 Oct;84(20):10488-500. doi: 10.1128/JVI.00894-10. Epub 2010 Aug 4.

7.

Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization.

Bu W, Palmeri D, Krishnan R, Marin R, Aris VM, Soteropoulos P, Lukac DM.

J Virol. 2008 Nov;82(21):10709-23. doi: 10.1128/JVI.01012-08. Epub 2008 Aug 20.

8.

Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein.

Palmeri D, Spadavecchia S, Carroll KD, Lukac DM.

J Virol. 2007 Dec;81(24):13299-314. Epub 2007 Oct 3.

10.

Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta lytic switch protein functions as a tetramer.

Bu W, Carroll KD, Palmeri D, Lukac DM.

J Virol. 2007 Jun;81(11):5788-806. Epub 2007 Mar 28.

11.

Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.

Carroll KD, Bu W, Palmeri D, Spadavecchia S, Lynch SJ, Marras SA, Tyagi S, Lukac DM.

J Virol. 2006 Oct;80(19):9697-709.

12.

Directed donation: what is a transplant center to do?

Palmeri D.

Nephrol Nurs J. 2005 Nov-Dec;32(6):701-2. No abstract available.

PMID:
16425823
13.

Rheological and cohesive properties of hyaluronic acid.

Falcone SJ, Palmeri DM, Berg RA.

J Biomed Mater Res A. 2006 Mar 15;76(4):721-8.

PMID:
16315193
14.

Differential gene expression profile of human tonsil high endothelial cells: implications for lymphocyte trafficking.

Palmeri D, Zuo FR, Rosen SD, Hemmerich S.

J Leukoc Biol. 2004 May;75(5):910-27. Epub 2004 Feb 3.

PMID:
14761935
15.

Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Dourmishev LA, Dourmishev AL, Palmeri D, Schwartz RA, Lukac DM.

Microbiol Mol Biol Rev. 2003 Jun;67(2):175-212, table of contents. Review.

16.
17.
19.

Multiple perspectives on nutrition education needs of low-income Hispanics.

Palmeri D, Auld GW, Taylor T, Kendall P, Anderson J.

J Community Health. 1998 Aug;23(4):301-16.

PMID:
9693987
20.

Strength, balance and gait before and after kidney transplantation.

Bohannon RW, Smith J, Hull D, Palmeri D, Barnhard R.

Int J Rehabil Res. 1997 Jun;20(2):199-203. No abstract available.

PMID:
9226504
22.

Deficits in lower extremity muscle and gait performance among renal transplant candidates.

Bohannon RW, Smith J, Hull D, Palmeri D, Barnhard R.

Arch Phys Med Rehabil. 1995 Jun;76(6):547-51.

PMID:
7763154
23.

Scanning mutagenesis of the arginine-rich region of the human immunodeficiency virus type 1 Rev trans activator.

Hammerschmid M, Palmeri D, Ruhl M, Jaksche H, Weichselbraun I, Böhnlein E, Malim MH, Hauber J.

J Virol. 1994 Nov;68(11):7329-35.

24.

Muscle strength impairments and gait performance deficits in kidney transplantation candidates.

Bohannon RW, Hull D, Palmeri D.

Am J Kidney Dis. 1994 Sep;24(3):480-5.

PMID:
8079973
25.

Functional analysis of the N-terminal domain of Tat protein of the human immunodeficiency virus type 1.

Reddy MV, Desai M, Jeyapaul J, Prasad DD, Seshamma T, Palmeri D, Khan SA.

Oncogene. 1992 Sep;7(9):1743-8.

PMID:
1501886
26.

Noncompliance in organ transplant recipients.

Swanson MA, Palmeri D, Vossler ED, Bartus SA, Hull D, Schweizer RT.

Pharmacotherapy. 1991;11(6):173S-174S.

PMID:
1771143
27.

Noncompliance in organ transplant recipients.

Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S.

Transplantation. 1990 Feb;49(2):374-7.

PMID:
2305467
28.

Noncompliance in renal transplant recipients: evaluation by socioeconomic groups.

Rovelli M, Palmeri D, Vossler E, Bartus S, Hull D, Schweizer R.

Transplant Proc. 1989 Dec;21(6):3979-81. No abstract available.

PMID:
2609425
29.

Noncompliance in organ transplant recipients.

Rovelli M, Palmeri D, Vossler E, Bartus S, Hull D, Schweizer R.

Transplant Proc. 1989 Feb;21(1 Pt 1):833-4. No abstract available.

PMID:
2650282
30.

Complex immunosuppressive protocols increase the need for patient education.

Rovelli M, Palmeri DL.

ANNA J. 1986 Aug;13(4):194-5, 222. No abstract available.

PMID:
3638946

Supplemental Content

Loading ...
Support Center